Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

MorphoSys and Heptares enter GPCR antibody agreement

Feb. 13, 2013

RQx Pharmaceuticals and Genentech form drug discovery collaboration

Feb. 13, 2013

Lycera enters into new collaboration with Merck & Co.

Feb. 13, 2013

Bayer HealthCare to coordinate newly founded pan-European consortium

Feb. 11, 2013

Kymab launches program to develop monoclonal antibody therapeutics

Feb. 5, 2013

Mobile ELISA device allows disease testing and transmission of results

Feb. 1, 2013

Phylogica receives milestone payment under collaboration with Janssen Biotech

Feb. 1, 2013

Amunix enters into licensing agreement with Janssen Biotech

Jan. 22, 2013

Researchers design a gene knockout mouse using TALEN-mediated mutagenesis in zygotes

Jan. 21, 2013

Omeros' CRA technology identifies small molecules for Class B GPCR

Jan. 18, 2013

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...